ATA 2014 American Thyroid Association (ATA) Guidelines on Thyroid Nodules and Differentiated Thyroid Cancer Highlights, Consensus, and Controversies

Program: Pre-Conference Events
Friday, June 20, 2014: 12:30 PM-5:30 PM
W183 BC (McCormick Place West Building)

Registration is required for this session:
Registration Rates: ATA/ENDO members - $105 Non-members - $145 Trainees - $25

Full Program
  • 2014 ATA DTC Guidelines Satellite Symp Agenda 4-8-2014.doc (53.5 kB)
  • Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. A large amount of new information and evidence grading processes has become available since the 2009 guidelines prompting the ATA to develop new and updated evidence-based recommendations to assist in the clinical management of patients with thyroid nodules and differentiated thyroid cancer.

    Authors from the international community of thyroid specialists in endocrinology and surgery will discuss recently published guidelines with special focus on:

    • Case based applications of the revised guidelines
    • New guidelines in 2014
    • Contemporary optimal care for patients with thyroid nodules and differentiated thyroid cancer


    12:30 - 12:35 PM
    Welcom and Introduction
    Bryan R Haugen, MD, Univ of Colorado Sch of Med

    12:35 - 12:45 PM
    Process of Devleopment and Format of the 2014 Nodules/DTC Guidelines
    Bryan R Haugen, MD,Univ of Colorado Sch of Med

    12:45 - 1:50 PM
    Approach to Patients with Thyroid Nodules
         Use of Neck US to Guide FNA Decision-Making 
         Susan J Mandel, MD, Univ of Pennsylvania
         Cytologic and Surgical Pathology Considerations 
         Yuri Nikiforov, MD, PhD, Univ of Pittsburg Med Ctr
         Use of Molecular Markers to Guide Decision-Making 
         David L Steward, MD, Univ of Cincinnati

         Questions & Answers

    1:50 - 3:25 PM
    Approaches to Initial Therapy for DTC

         Preoperative Disease Mapping and Voice Assessment
         Gregory W Randolph, MD, Massachusetts Eye and Ear Infirmary
         Surgical Approach and Considerations
         Julie Ann Sosa, MD, Duke Univ Sch of Med
         Staging and Risk Stratification Updates
         Erik K Alexander, MD, Brigham & Women's Hosp
         Updates on Radioactive Iodine Use - Consideration, Dosing, Preparation
         Anna M Sawka, MD, Toronto Gen Hosp
         Integrating Response to Therapy in Monitoring Management
         R Michael Tuttle, MD, Memorial Sloan-Kettering Cancer Ctr
         Questions & Answers

    3:25 - 3:45 PM

    3:45 - 4:30 PM
    Approaches to Patients wiht Advanced DTC
         Monitoring and Directed Therapy for Radioactive Iodine-Refractory DTC
         Furio Pacini, MD, Univ of Siena
         Systemic Therapy and Clinical Trials for Radioactive Iodine-Refractory DTC
         Keith C Bible, MD, PhD, Mayo Clin

         Questions & Answers

    4:30 - 5:20 PM
    Case-Based Discussion on Practical Applications of the 2014 Nodules/DTC Guidelines
    Bryan R Haugen, MD/Panel of Speakers

    See more of: Pre-Conference Events